Discontinuation of OxyNorm®, MS Mono® and Sevredol®

HPS Pharmacies wish to advise that Mundipharma is discontinuing the following opioid products:

• OxyNorm^® (oxycodone) capsules;
• MS Mono^® (morphine sulfate) modified-release capsules; and
• Sevredol^® (morphine sulfate) tablets

Mundipharma has provided the following estimated dates of discontinuation from the market based on current demand.

These dates are estimates only and may be updated on the Medicine shortage reports database if there are any changes in demand.

Retain this notice in a prominent position, including in other related business units for at least one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Mundipharma on 1800 188 009 or your pharmacist at HPS Pharmacies.

Download PDF